Finding the characterized proteins for SLC5A8 (sodium-coupled monocarboxylate transporter) in propionate catabolism
Or see clustering for step SLC5A8
Or see all steps for propionate catabolism
Or cluster curated proteins matching a keyword
Definition of SLC5A8
Fetched 1 sequences
Running ublast to find other characterized proteins with 40% identity and 70% coverage
Found hits to 9 other characterized sequences. (Found 10 hits including self hits.)
(Sequences that are similar to these will not be high-confidence candidates for SLC5A8.)
SC5A8_MOUSE / Q8BYF6 Sodium-coupled monocarboxylate transporter 1; Electrogenic sodium monocarboxylate cotransporter; Solute carrier family 5 member 8 from Mus musculus (Mouse)
PFams: SSF
611 amino acids: PaperBLAST, CDD, SwissProt::Q8BYF6
86% identical to
SC5A8_HUMAN / Q8N695 Sodium-coupled monocarboxylate transporter 1; Apical iodide transporter; Electrogenic sodium monocarboxylate cotransporter; Sodium iodide-related cotransporter; Solute carrier family 5 member 8 from Homo sapiens (Human)
TC 2.A.21.5.3 / Q8N695 Na+-dependent short chain fatty acid transporter SLC5A8 (tumor suppressor gene product, down-regulated in colon cancer) (substrates: lactate, pyruvate, acetate, propionate, butyrate (Km ≈1 mM)) [propionate:Na+ = 1:3] (Miyauchi et al., 2004). Pyroglutamate (5-oxoproline) is also transported in a Na+- coupled mechanism (Miyauchi et al., 2010). SMCT1 and SMCT2 may transport monocarboxylate drugs (e.g. nicotinate and its derivatives) across the intestinal brush boarder membrane
PFams: SSF
610 amino acids: PaperBLAST, CDD
SC5A8_XENLA / Q7SYH5 Sodium-coupled monocarboxylate transporter 1; Electrogenic sodium monocarboxylate cotransporter; xSMCTe; Sodium solute transporter Vito; Solute carrier family 5 member 8 from Xenopus laevis (African clawed frog)
PFams: SSF
622 amino acids: PaperBLAST, CDD, SwissProt::Q7SYH5
72% identical to
SC5A8_HUMAN / Q8N695 Sodium-coupled monocarboxylate transporter 1; Apical iodide transporter; Electrogenic sodium monocarboxylate cotransporter; Sodium iodide-related cotransporter; Solute carrier family 5 member 8 from Homo sapiens (Human)
TC 2.A.21.5.3 / Q8N695 Na+-dependent short chain fatty acid transporter SLC5A8 (tumor suppressor gene product, down-regulated in colon cancer) (substrates: lactate, pyruvate, acetate, propionate, butyrate (Km ≈1 mM)) [propionate:Na+ = 1:3] (Miyauchi et al., 2004). Pyroglutamate (5-oxoproline) is also transported in a Na+- coupled mechanism (Miyauchi et al., 2010). SMCT1 and SMCT2 may transport monocarboxylate drugs (e.g. nicotinate and its derivatives) across the intestinal brush boarder membrane
PFams: SSF
610 amino acids: PaperBLAST, CDD
SC5A8_DANRE / Q3ZMH1 Sodium-coupled monocarboxylate transporter 1; Electrogenic sodium monocarboxylate cotransporter; zSMCTe; Sodium solute symporter family 5 member 8 protein; Solute carrier family 5 member 8 from Danio rerio (Zebrafish) (Brachydanio rerio)
TC 2.A.21.5.5 / Q3ZMH1 The high affinity (Km (lactate) = 0.2mM) electrogenic Na+ monocarboxylate (lactate, pyruvate, butyrate, nicotinate) transporter, SMCTe from Danio rerio (Zebrafish) (Brachydanio rerio)
RF|NP_001030141.1 sodium-coupled monocarboxylate transporter 1 from Danio rerio
PFams: SSF
610 amino acids: PaperBLAST, CDD, SwissProt::Q3ZMH1
57% identical to
SC5A8_HUMAN / Q8N695 Sodium-coupled monocarboxylate transporter 1; Apical iodide transporter; Electrogenic sodium monocarboxylate cotransporter; Sodium iodide-related cotransporter; Solute carrier family 5 member 8 from Homo sapiens (Human)
TC 2.A.21.5.3 / Q8N695 Na+-dependent short chain fatty acid transporter SLC5A8 (tumor suppressor gene product, down-regulated in colon cancer) (substrates: lactate, pyruvate, acetate, propionate, butyrate (Km ≈1 mM)) [propionate:Na+ = 1:3] (Miyauchi et al., 2004). Pyroglutamate (5-oxoproline) is also transported in a Na+- coupled mechanism (Miyauchi et al., 2010). SMCT1 and SMCT2 may transport monocarboxylate drugs (e.g. nicotinate and its derivatives) across the intestinal brush boarder membrane
PFams: SSF
610 amino acids: PaperBLAST, CDD
SC5AC_MOUSE / Q49B93 Sodium-coupled monocarboxylate transporter 2; Electroneutral sodium monocarboxylate cotransporter; Low-affinity sodium-lactate cotransporter; Solute carrier family 5 member 12 from Mus musculus (Mouse)
PFams: SSF
619 amino acids: PaperBLAST, CDD, SwissProt::Q49B93
56% identical to
SC5A8_HUMAN / Q8N695 Sodium-coupled monocarboxylate transporter 1; Apical iodide transporter; Electrogenic sodium monocarboxylate cotransporter; Sodium iodide-related cotransporter; Solute carrier family 5 member 8 from Homo sapiens (Human)
TC 2.A.21.5.3 / Q8N695 Na+-dependent short chain fatty acid transporter SLC5A8 (tumor suppressor gene product, down-regulated in colon cancer) (substrates: lactate, pyruvate, acetate, propionate, butyrate (Km ≈1 mM)) [propionate:Na+ = 1:3] (Miyauchi et al., 2004). Pyroglutamate (5-oxoproline) is also transported in a Na+- coupled mechanism (Miyauchi et al., 2010). SMCT1 and SMCT2 may transport monocarboxylate drugs (e.g. nicotinate and its derivatives) across the intestinal brush boarder membrane
PFams: SSF
610 amino acids: PaperBLAST, CDD
SC5AC_HUMAN / Q1EHB4 Sodium-coupled monocarboxylate transporter 2; Electroneutral sodium monocarboxylate cotransporter; Low-affinity sodium-lactate cotransporter; Solute carrier family 5 member 12 from Homo sapiens (Human)
TC 2.A.21.5.6 / Q1EHB4 Sodium-coupled monocarboxylate transporter 2 (Electroneutral sodium monocarboxylate cotransporter) (Low-affinity sodium-lactate cotransporter) (Solute carrier family 5 member 12) from Homo sapiens
PFams: SSF
618 amino acids: PaperBLAST, CDD, SwissProt::Q1EHB4
55% identical to
SC5A8_HUMAN / Q8N695 Sodium-coupled monocarboxylate transporter 1; Apical iodide transporter; Electrogenic sodium monocarboxylate cotransporter; Sodium iodide-related cotransporter; Solute carrier family 5 member 8 from Homo sapiens (Human)
TC 2.A.21.5.3 / Q8N695 Na+-dependent short chain fatty acid transporter SLC5A8 (tumor suppressor gene product, down-regulated in colon cancer) (substrates: lactate, pyruvate, acetate, propionate, butyrate (Km ≈1 mM)) [propionate:Na+ = 1:3] (Miyauchi et al., 2004). Pyroglutamate (5-oxoproline) is also transported in a Na+- coupled mechanism (Miyauchi et al., 2010). SMCT1 and SMCT2 may transport monocarboxylate drugs (e.g. nicotinate and its derivatives) across the intestinal brush boarder membrane
PFams: SSF
610 amino acids: PaperBLAST, CDD
SC5AC_DANRE / Q7T384 Sodium-coupled monocarboxylate transporter 2; Electroneutral sodium monocarboxylate cotransporter; zSMCTn; Low-affinity sodium-lactate cotransporter; Solute carrier family 5 member 12; zSLC5A12 from Danio rerio (Zebrafish) (Brachydanio rerio)
TC 2.A.21.5.4 / Q7T384 The low affinity (Km (lactate) = 2mM) electroneutral Na+:monocarboxylate (lactate, pyruvate, butyrate, nicotinate) transporter, SMCTn from Danio rerio (Zebrafish) (Brachydanio rerio)
GB|AAW55812.1 sodium-coupled monocarboxylate transporter 2 from Danio rerio
PFams: SSF
623 amino acids: PaperBLAST, CDD, SwissProt::Q7T384
55% identical to
SC5A8_HUMAN / Q8N695 Sodium-coupled monocarboxylate transporter 1; Apical iodide transporter; Electrogenic sodium monocarboxylate cotransporter; Sodium iodide-related cotransporter; Solute carrier family 5 member 8 from Homo sapiens (Human)
TC 2.A.21.5.3 / Q8N695 Na+-dependent short chain fatty acid transporter SLC5A8 (tumor suppressor gene product, down-regulated in colon cancer) (substrates: lactate, pyruvate, acetate, propionate, butyrate (Km ≈1 mM)) [propionate:Na+ = 1:3] (Miyauchi et al., 2004). Pyroglutamate (5-oxoproline) is also transported in a Na+- coupled mechanism (Miyauchi et al., 2010). SMCT1 and SMCT2 may transport monocarboxylate drugs (e.g. nicotinate and its derivatives) across the intestinal brush boarder membrane
PFams: SSF
610 amino acids: PaperBLAST, CDD
SC5A5_HUMAN / Q92911 Sodium/iodide cotransporter; Na(+)/I(-) cotransporter; Sodium-iodide symporter; Na(+)/I(-) symporter; Solute carrier family 5 member 5 from Homo sapiens (Human)
TC 2.A.21.5.1 / Q92911 Sodium iodide symporter (NIS; also transports other monovalent anions including: ClO3-, SCN-, SeCN-, NO3-, Br-, BF4-, IO4- and BrO3-). It mediates electroneutral active transport of the environmental pollutant perchlorate (Dohan et al., 2007). Five beta-OH group-containing residues (Thr-351, Ser-353, Thr-354, Ser-356, and Thr-357) and Asn-360, all of which putatively face the same side of the helix in TMS IX, plus Asp-369, located in the membrane/cytosol interface, play key roles in NIS function and seem to be involved in Na+ binding/translocation (De la Vieja et al. 2007). Thr-354 is essential for iodide uptake (Tatsumi et al., 2010). The stoichiometry is Na+:I-= 2:1. The G39R mutant (congenital) is inactive. G93 is a pivot for the inwardly to outwardly conformational change from Homo sapiens (Human)
PFams: SSF
643 amino acids: PaperBLAST, CDD, SwissProt::Q92911
51% identical to
SC5A8_HUMAN / Q8N695 Sodium-coupled monocarboxylate transporter 1; Apical iodide transporter; Electrogenic sodium monocarboxylate cotransporter; Sodium iodide-related cotransporter; Solute carrier family 5 member 8 from Homo sapiens (Human)
TC 2.A.21.5.3 / Q8N695 Na+-dependent short chain fatty acid transporter SLC5A8 (tumor suppressor gene product, down-regulated in colon cancer) (substrates: lactate, pyruvate, acetate, propionate, butyrate (Km ≈1 mM)) [propionate:Na+ = 1:3] (Miyauchi et al., 2004). Pyroglutamate (5-oxoproline) is also transported in a Na+- coupled mechanism (Miyauchi et al., 2010). SMCT1 and SMCT2 may transport monocarboxylate drugs (e.g. nicotinate and its derivatives) across the intestinal brush boarder membrane
PFams: SSF
610 amino acids: PaperBLAST, CDD
TC 2.A.21.5.7 / Q9Y289 Sodium-dependent multivitamin transporter (Na+-dependent multivitamin transporter) (Solute carrier family 5 member 6) from Homo sapiens
PFams: SSF
635 amino acids: PaperBLAST, CDD, TCDB::Q9Y289
45% identical to
SC5A8_HUMAN / Q8N695 Sodium-coupled monocarboxylate transporter 1; Apical iodide transporter; Electrogenic sodium monocarboxylate cotransporter; Sodium iodide-related cotransporter; Solute carrier family 5 member 8 from Homo sapiens (Human)
TC 2.A.21.5.3 / Q8N695 Na+-dependent short chain fatty acid transporter SLC5A8 (tumor suppressor gene product, down-regulated in colon cancer) (substrates: lactate, pyruvate, acetate, propionate, butyrate (Km ≈1 mM)) [propionate:Na+ = 1:3] (Miyauchi et al., 2004). Pyroglutamate (5-oxoproline) is also transported in a Na+- coupled mechanism (Miyauchi et al., 2010). SMCT1 and SMCT2 may transport monocarboxylate drugs (e.g. nicotinate and its derivatives) across the intestinal brush boarder membrane
PFams: SSF
610 amino acids: PaperBLAST, CDD
TC 2.A.21.5.2 / O70247 Na+-dependent multivitamin (pantothenate, biotin, lipoate) transporter (de Carvalho and Quick 2011). Broad specificity. May be useful for drug delivery using biotin-conjugated drugs such as Biotin-Acyclovir (B-ACV) from Rattus norvegicus (Rat)
PFams: SSF
634 amino acids: PaperBLAST, CDD, TCDB::O70247
47% identical to
SC5A8_HUMAN / Q8N695 Sodium-coupled monocarboxylate transporter 1; Apical iodide transporter; Electrogenic sodium monocarboxylate cotransporter; Sodium iodide-related cotransporter; Solute carrier family 5 member 8 from Homo sapiens (Human)
TC 2.A.21.5.3 / Q8N695 Na+-dependent short chain fatty acid transporter SLC5A8 (tumor suppressor gene product, down-regulated in colon cancer) (substrates: lactate, pyruvate, acetate, propionate, butyrate (Km ≈1 mM)) [propionate:Na+ = 1:3] (Miyauchi et al., 2004). Pyroglutamate (5-oxoproline) is also transported in a Na+- coupled mechanism (Miyauchi et al., 2010). SMCT1 and SMCT2 may transport monocarboxylate drugs (e.g. nicotinate and its derivatives) across the intestinal brush boarder membrane
PFams: SSF
610 amino acids: PaperBLAST, CDD